0001562180-24-003193.txt : 20240402 0001562180-24-003193.hdr.sgml : 20240402 20240402172752 ACCESSION NUMBER: 0001562180-24-003193 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240330 FILED AS OF DATE: 20240402 DATE AS OF CHANGE: 20240402 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Paggiarino Dario A. CENTRAL INDEX KEY: 0001574261 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51122 FILM NUMBER: 24815765 MAIL ADDRESS: STREET 1: 4025 SORRENTO VALLEY BLVD. CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EyePoint Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001314102 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 262774444 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 480 PLEASANT STREET STREET 2: SUITE B300 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617-926-5000 MAIL ADDRESS: STREET 1: 480 PLEASANT STREET STREET 2: SUITE B300 CITY: WATERTOWN STATE: MA ZIP: 02472 FORMER COMPANY: FORMER CONFORMED NAME: pSivida Corp. DATE OF NAME CHANGE: 20080619 FORMER COMPANY: FORMER CONFORMED NAME: pSivida LTD DATE OF NAME CHANGE: 20050111 4 1 primarydocument.xml PRIMARY DOCUMENT X0508 4 2024-03-30 true 0001314102 EyePoint Pharmaceuticals, Inc. EYPT 0001574261 Paggiarino Dario A. C/O EYEPOINT PHARMACEUTICALS, INC. 480 PLEASANT STREET WATERTOWN MA 02472 false true false false Chief Medical Officer false Common Stock 2024-03-30 4 M false 5834.00 0.00 A 48056.00 D Common Stock 2024-03-30 4 M false 30570.00 0.00 A 78626.00 D Common Stock 2024-03-30 4 M false 14000.00 0.00 A 92626.00 D Common Stock 2024-03-30 4 F false 15493.00 20.67 D 77133.00 D Common Stock 2024-03-30 4 F false 2957.00 20.67 D 74176.00 D Common Stock 2024-03-30 4 F false 7096.00 20.67 D 67080.00 D Restricted Stock Units 0.00 2024-03-30 4 M false 30570.00 0.00 D Common Stock 30570.00 0.00 D Restricted Stock Units 0.00 2024-03-30 4 M false 5834.00 0.00 D Common Stock 5834.00 0.00 D Restricted Stock Units 0.00 2024-03-30 4 M false 14000.00 0.00 D Common Stock 14000.00 0.00 D No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units The restricted stock units will vest in three ratable annual installments beginning January 6, 2024. The restricted stock units will vest in three ratable annual installments beginning February 9, 2023. The restricted stock units will vest in three ratable annual installments beginning January 5, 2025. /s/ Ron Honig, Attorney-in-Fact 2024-04-02